Profile
Li Deng-Ke served as President, CEO, CFO, Director & CAO at Rich Pharmaceuticals, Inc. from 2012 to 2013.
Prior to that, he worked as a Technician at KTV Ltd.
Mr. Deng-Ke received his undergraduate degree from Sichuan Normal University in 2006.
Former positions of Li Deng-Ke
| Companies | Position | End |
|---|---|---|
| RICH PHARMACEUTICALS, INC. | Director of Finance/CFO | 2013-03-28 |
| KTV Ltd. | Corporate Officer/Principal | - |
Training of Li Deng-Ke
| Sichuan Normal University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Rich Pharmaceuticals, Inc.
 Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
| KTV Ltd. |
- Stock Market
- Insiders
- Li Deng-Ke
